Edition:
United Kingdom

Karo Pharma AB (KARO.ST)

KARO.ST on Stockholm Stock Exchange

29.30SEK
21 Jun 2018
Change (% chg)

-0.05kr (-0.17%)
Prev Close
29.35kr
Open
29.40kr
Day's High
29.70kr
Day's Low
29.15kr
Volume
775,876
Avg. Vol
555,555
52-wk High
41.68kr
52-wk Low
25.25kr

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 238.72 -0.399
Sep '17 137.09 0.128
Jun '17 142.46 0.176
Mar '17 139.33 0.231
FY 2016 Dec '16 96.45 1.276
Sep '16 85.16 0.056
Jun '16 81.91 -0.040
Mar '16 82.30 0.049
 
*Note: Units in Millions ofSwedish Krona
**Note: Units in Swedish Krona

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 1 1,652.00 1,652.00 1,652.00 --
Year Ending Dec-19 1 2,027.00 2,027.00 2,027.00 --
Earnings (per share)
Year Ending Dec-18 1 1.67 1.67 1.67 --
Year Ending Dec-19 1 2.17 2.17 2.17 --
Sales and Profit Figures in Swedish Krona (SEK);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 20.39 82.81 32.74
P/E High - Last 5 Yrs. 17.52 289.15 45.73
P/E Low - Last 5 Yrs. 17.52 90.24 24.23
Beta 0.71 0.91 0.88
Price to Sales (TTM) 7.06 109.18 5.71
Price to Book (MRQ) 3.08 13.44 5.37
Price to Tangible Book (MRQ) -- 13.96 6.94
Price to Cash Flow (TTM) 19.20 70.39 23.32
% Owned Institutions -- 13.84 2.17

Dividends

  Company industry sector
Dividend Yield 0.70 0.34 1.50
Dividend Yield - 5 Year Avg 0.35 0.25 1.51
Dividend 5 Year Growth Rate -- 1.64 5.32
Payout Ratio(TTM) 0.00 15.83 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 73.93 392.54 7.89
Sales (TTM) vs TTM 1 Yr. Ago 100.57 77.35 5.68
Sales - 5 Yr. Growth Rate -- 32.11 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago 541.36 24.53 19.38
EPS (TTM) vs TTM 1 Yr. Ago 278.13 -- --
EPS - 5 Yr. Growth Rate -- 39.08 10.78
Capital Spending - 5 Yr. Growth Rate 15.70 40.34 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.83 2.19
Current Ratio (MRQ) 2.25 5.26 2.98
LT Debt to Equity (MRQ) 45.78 24.54 12.19
Total Debt to Equity (MRQ) 45.78 26.17 16.46
Interest Coverage (TTM) -9.49 -97.42 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 50.37 40.81 54.46
Gross Margin - 5 Yr. Avg. -- 51.76 52.22
EBITD Margin (TTM) 28.58 -- --
EBITD - 5 Yr. Avg -36.86 -564.12 10.98
Operating Margin (TTM) 20.58 -706.11 4.74
Operating Margin - 5 Yr. Avg. -43.06 -585.15 6.41
Pre-Tax Margin (TTM) 14.24 -681.03 5.58
Pre-Tax Margin - 5 Yr. Avg. -44.64 -588.45 6.83
Net Profit Margin (TTM) 28.74 -682.46 1.88
Net Profit Margin - 5 Yr. Avg. -30.81 -591.46 3.10
Effective Tax Rate (TTM) -101.89 22.64 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.26 23.95

Efficiency

  Company industry sector
Revenue/Employee (TTM) 6,716,145 22,312,275 846,855,748
Net Income/Employee (TTM) 1,930,536 2,947,385 99,619,396
Receivable Turnover (TTM) -- 19.92 5.78
Inventory Turnover (TTM) -- 2.37 3.35
Asset Turnover (TTM) 0.37 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 10.69 -0.70 10.95
Return on Assets - 5 Yr. Avg. -9.05 -0.06 12.32
Return on Investment (TTM) 11.70 2.00 14.38
Return on Investment - 5 Yr. Avg. -13.05 2.81 16.11
Return on Equity (TTM) 15.82 3.49 16.08
Return on Equity - 5 Yr. Avg. -18.16 4.33 17.41
  1 Year 3 Year 5 Year
Sales % 402.58 94.73 --
EPS (TTM) % 192.15 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Karo Pharma AB

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 3.65 -- 99 53
13 Week -2.93 -- 91 69
26 Week 19.15 -- 99 77
52 Week 13.66 -- 99 48
YTD 51.68 -- 99 59
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 3.41%
# of Holders: 14
Total Shares Held: 5,601,929
3 Mo. Net Change: 138,356
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 5
# Reduced Positions: 1
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.